Glycosuria

R18_GLYCOSURIA

renal glycosuria: An autosomal inherited disorder due to defective reabsorption of GLUCOSE by the PROXIMAL RENAL TUBULES. The urinary loss of glucose can reach beyond 50 g/day. It is attributed to the mutations in the SODIUM-GLUCOSE TRANSPORTER 2 encoded by the SLC5A2 gene.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — R81 Cause of death: ICD-10 — R81 2 out of 7 registries used, show all original rules.	67
4. Check minimum number of events None	67
5. Include endpoints None	67
6. Filter based on genotype QC (FinnGen only)	62

Control definitions (FinnGen only)

Control exclude: R18_ABNORMAL_FINDI_EXAMI_URINE_WO_DIAGNOSIS

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: R8[0-2]
Name in latin: Glucosuria

NAME	R18_GLYCOSURIA
CONTROL_EXCLUDE	R18_ABNORMAL_FINDI_EXAMI_URINE_WO_DIAGNOSIS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	R81
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	R81
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Glycosuria based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	62	46	16
Unadjusted period prevalence (%)	0.01	0.02	0.01
Median age at first event (years)	39.44	30.66	64.69

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
67: Matched controls
670

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

R81

ICD-10 Finland

Glycosuria

+∞

96.2

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

4.16

5.12

2.2

2.3

26.53

23.46

0.36

(3026008) Bacteria identified in Urine by Culture

154

2.89

4.28

3.6

2.3

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

5.19

3.02

3.0

12.5

132.13

123.71

g/l

—

(3012544) pH of Venous blood

3.52

2.96

4.4

9.3

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3.43

2.88

4.5

9.1

6.10

5.93

kpa

0.20

(3001122) Ferritin [Mass/volume] in Serum or Plasma

224

2.31

2.83

3.5

2.9

69.22

70.73

ug/l

0.04

210

(3027273) Bicarbonate [Moles/volume] in Venous blood

6.46

2.76

3.0

1.6

25.13

24.17

mmol/l

—

(3024354) Oxygen [Partial pressure] in Venous blood

3.49

2.56

3.9

10.3

4.62

5.19

kpa

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3.68

2.50

1.4

1.7

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

4.47

2.43

2.7

2.1

—

(3037467) Urinalysis macro (dipstick) panel - Urine

361

2.33

2.42

5.8

3.7

—

(3019198) Lymphocytes [#/volume] in Blood

254

2.15

2.39

7.8

6.4

1.89

1.97

e9/l

0.25

231

(3001604) Monocytes [#/volume] in Blood

245

2.14

2.38

7.7

6.6

0.59

0.55

e9/l

0.52

218

(3006315) Basophils [#/volume] in Blood

245

2.14

2.38

7.8

6.6

0.03

0.04

e9/l

0.19

217

(3020682) Albumin/Creatinine [Ratio] in Urine

111

2.30

2.35

4.4

3.4

2.49

15.34

mg/mmol

0.80

(3000330) Specific gravity of Urine by Test strip

4.21

2.32

2.4

2.2

—

(3022145) Colonoscopy Study observation

3.08

2.25

1.2

1.3

—

(3018010) Neutrophils/100 leukocytes in Blood

241

2.07

2.20

8.3

6.1

59.47

55.82

1.30

227

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

180

2.08

2.16

5.4

3.4

—

(3022217) INR in Platelet poor plasma by Coagulation assay

155

2.11

2.15

12.1

10.7

1.34

1.16

inr

0.39

(3023103) Potassium [Moles/volume] in Serum or Plasma

493

2.65

2.12

24.3

12.0

3.89

3.92

mmol/l

0.29

475

(3019550) Sodium [Moles/volume] in Serum or Plasma

494

2.62

2.11

24.3

11.9

139.46

139.65

mmol/l

0.31

478

(3022096) Basophils/100 leukocytes in Blood

226

2.02

2.09

8.8

6.3

0.49

0.62

0.81

210

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2.46

2.05

1.4

2.0

—

(3002030) Lymphocytes/100 leukocytes in Blood

246

2.00

2.03

8.7

6.2

26.74

30.21

1.56

233

(3019069) Monocytes/100 leukocytes in Blood

237

2.00

2.02

8.9

6.6

8.44

8.19

0.20

223

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2.59

2.01

2.1

1.6

—

(40760892) CBC W Ordered Manual Differential panel - Blood

221

1.97

1.95

8.8

7.4

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2.54

1.94

2.8

1.7

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

128

2.07

1.91

1.7

1.4

0.38

3.07

u/ml

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

4.41

1.85

4.0

2.2

55.50

50.40

—

(3003396) Base excess in Arterial blood by calculation

2.55

1.82

8.3

6.2

4.80

1.83

mmol/l

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

528

2.73

1.80

18.6

11.9

70.43

69.50

umol/l

0.11

528

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

149

1.95

1.73

1.5

1.7

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

3.36

1.70

1.2

1.7

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

3.77

1.64

3.2

1.9

134.40

129.11

g/l

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

160

1.90

1.63

3.6

3.2

33.00

30.19

u/l

0.25

154

(3013139) Helicobacter pylori Ag [Presence] in Stool

2.89

1.47

1.2

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1.96

1.44

1.7

1.5

17.69

21.46

nmol/l

0.55

(3021601) Nitrite [Presence] in Urine by Test strip

238

1.76

1.44

7.6

4.8

0.00

estimate

—

(3035350) Ketones [Presence] in Urine by Test strip

238

1.76

1.44

5.7

3.4

0.00

estimate

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2.57

1.43

5.1

11.0

25.00

24.66

mmol/l

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2.76

1.40

12.0

6.6

—

(3003327) Ova and parasites identified in Stool by Light microscopy

3.09

1.38

1.6

1.8

—

(3012516) Albumin [Mass/volume] in Urine

109

1.89

1.36

3.1

3.0

16.72

120.60

mg/l

0.85

(3023511) Choriogonadotropin [Units/volume] in Urine

2.64

1.33

1.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2.00

1.33

2.6

1.8

—

(3041096) Erythrocytes [Presence] in Urine by Automated

144

1.79

1.31

4.0

2.9

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

532

2.22

1.28

12.1

8.6

25.23

24.82

u/l

0.06

512

(3002385) Erythrocyte distribution width [Ratio]

469

1.96

1.28

24.6

13.4

14.51

14.29

0.13

463

(3009261) Glucose [Presence] in Urine by Test strip

245

1.68

1.25

6.1

3.4

0.00

estimate

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

2.18

1.24

4.9

9.5

107.00

104.10

mmol/l

—

(3005322) IgE [Units/volume] in Serum or Plasma

2.13

1.16

1.3

1.2

105.20

238.67

u/ml

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

116

1.75

1.11

5.1

3.6

13.99

23.03

ng/l

—

(3007853) Bacteria identified in Skin by Aerobe culture

2.05

1.07

3.1

1.6

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.18

1.06

1.0

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

516

1.92

1.05

20.2

11.2

20.72

21.11

mg/l

0.04

389

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2.05

1.00

3.1

2.8

—

(1761868) Lipid panel - Serum or Plasma

165

1.60

0.95

2.9

2.5

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2.10

0.89

1.2

1.1

—

(3023368) Bacteria identified in Blood by Culture

106

1.67

0.89

4.6

4.1

—

(3000494) Fungus identified in Specimen by Culture

1.84

0.86

2.5

1.5

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

160

1.56

0.85

2.6

1.8

92.05

90.74

pmol/l

0.05

(3021589) Normoblasts [#/volume] in Blood

225

1.51

0.84

13.1

8.7

0.00

e9/l

0.71

179

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1.90

0.81

13.3

12.0

24.28

25.63

mmol/l

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

229

1.47

0.76

2.5

—

(40768797) Stomach Pathology biopsy report

1.67

0.75

1.1

1.2

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

166

1.48

0.71

6.3

2.7

—

(3000991) Gas panel - Venous blood

1.74

0.71

14.1

7.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1.92

0.70

1.2

—

(3019060) Gas panel - Arterial blood

1.92

0.70

3.6

3.7

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1.66

0.67

3.0

3.9

34.14

35.79

—

(3013512) EKG study

1.57

0.64

3.8

3.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

125

1.48

0.61

2.1

2.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.00

0.61

0.0

1.4

—

(3042936) Bacteria identified in Isolate by Culture

1.49

0.55

3.6

1.8

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1.49

0.55

7.8

3.4

0.84

0.83

mmol/l

—

(3044889) 12 lead EKG panel

289

1.36

0.54

4.4

3.1

—

(4200892) Spirometry reversibility

1.59

0.54

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

434

1.37

0.49

4.5

3.6

—

(36660697) Celiac disease serology panel - Serum

1.51

0.48

1.7

1.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.49

0.46

1.2

1.4

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1.44

0.46

4.5

2.9

340.54

317.06

umol/l

0.47

(3029937) Albumin [Presence] in Urine by Test strip

125

1.37

0.42

8.4

3.5

0.00

estimate

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

135

1.35

0.40

1.5

1.6

—

(40761511) CBC panel - Blood by Automated count

547

1.45

0.39

17.3

9.6

—

(3007461) Platelets [#/volume] in Blood

584

1.50

0.36

28.7

16.6

278.39

257.77

e9/l

1.50

573

(3024731) MCV [Entitic volume]

585

1.48

0.35

28.7

16.5

89.76

89.83

0.04

577

(3000963) Hemoglobin [Mass/volume] in Blood

585

1.48

0.35

29.7

16.7

132.57

134.65

g/l

0.59

577

(3026361) Erythrocytes [#/volume] in Blood

585

1.48

0.35

28.7

16.6

4.44

4.52

e12/l

0.69

573

(3035941) MCH [Entitic mass]

585

1.48

0.35

28.6

16.5

29.86

29.93

0.11

576

(40768804) Tissue Pathology biopsy report

195

1.27

0.35

3.4

1.9

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1.42

0.33

3.7

4.6

1.67

1.68

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1.36

0.32

1.1

1.8

—

(3010813) Leukocytes [#/volume] in Blood

586

1.46

0.25

28.7

16.7

7.22

6.64

e9/l

1.51

573

(46235355) HIV 1 and 2 tests - Meaningful Use set

163

1.23

0.25

1.5

1.9

—

(40761536) Microorganisms panel - Urine sediment

1.38

0.24

8.2

3.0

—

(3022621) pH of Urine by Test strip

1.27

0.23

4.2

2.5

—

(3003694) ABO and Rh group [Type] in Blood

165

0.81

0.22

1.5

1.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.24

0.22

1.0

1.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

127

1.23

0.22

2.1

1.5

1.60

2.49

g/l

—

(4034850) Laboratory test

0.00

0.21

0.0

25.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.00

0.21

0.0

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.00

0.21

0.0

1.5

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

0.00

0.21

0.0

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

0.21

0.0

1.3

—

(36304419) Bacteria [Presence] in Urine

137

1.22

0.21

5.9

2.5

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

0.21

0.0

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

0.21

0.0

1.2

—

(3025130) Human papilloma virus identified in Specimen

0.00

0.21

0.0

2.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

0.00

0.20

0.0

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.19

0.18

2.9

1.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

120

1.21

0.18

2.2

2.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

0.74

0.18

1.4

1.5

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

458

1.17

0.17

17.2

9.6

89.76

90.20

ml/min/173m2

0.04

353

(3044640) Blood type and Crossmatch panel - Blood

143

1.16

0.13

2.1

2.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.18

0.10

1.3

1.7

—

(3000492) Spirometry study

1.09

0.10

2.2

1.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

107

1.15

0.09

2.2

2.0

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1.12

0.08

3.6

4.3

—

24.54

—

(21494755) Public health laboratory ask at order entry panel

1.10

0.08

1.1

1.2

—

(40758558) Short blood count panel - Blood

147

1.12

0.08

8.7

6.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.06

0.08

2.8

1.8

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1.04

0.07

11.3

2.2

2.70

2.45

mmol/l

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

123

1.07

0.02

1.8

1.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

105

1.06

0.00

8.3

3.6

—

(3019832) Treponema pallidum Ab [Presence] in Serum

116

1.04

0.00

1.8

1.6

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

0.00

0.0

1.1

—

(3002256) Pathology report gross observation

0.85

0.00

1.0

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

0.00

0.0

1.3

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.3

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

0.00

-0.00

0.0

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

0.00

-0.00

0.0

2.7

—

13.35

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.3

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.3

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

-0.00

0.0

1.7

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

7.77

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

1.61

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

-0.00

0.0

1.8

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

0.73

—

(3022806) Fractional oxyhemoglobin in Capillary blood

0.00

-0.00

0.0

1.3

—

91.23

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

-0.00

0.0

1.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

2.5

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

0.00

-0.00

0.0

1.3

—

(3023420) DNA double strand Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.5

—

(40768441) Liver Pathology biopsy report

0.00

-0.00

0.0

1.0

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

11.5

—

0.69

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

0.51

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

-0.00

0.0

1.7

—

(3004616) Nuclear Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.1

—

(21494815) CD4 cells/100 lymphocytes in Specimen

0.00

-0.00

0.0

2.6

—

36.64

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

0.00

-0.00

0.0

2.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.4

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

11.90

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

0.00

-0.00

0.0

1.4

—

453.14

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

0.00

-0.00

0.0

1.3

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

0.00

-0.00

0.0

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

0.00

-0.00

0.0

1.3

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.3

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

-0.00

0.0

3.9

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3036180) Methadone [Presence] in Urine

0.00

-0.00

0.0

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

0.00

-0.00

0.0

4.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: R18_GLYCOSURIA – Glycosuria

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Glycosuria

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Glycosuria (R18_GLYCOSURIA)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints